Clinical Trials List
Protocol NumberLOXO-BTK-20022 (J2N-OX-JZNO)
Active
2021-08-02 - 2026-09-18
Phase III
Recruiting1
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- CHENG-HONG TSAI Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
600 participants
